Yigal Koltin

Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel.

Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel.

Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel.

Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA.

QuantomiX Ltd. develops and markets capsules that enable real-time analysis of wet cells and tissue biopsies. The firm with the its QXTM capsule product line, wet samples, including cells and tissues biopsies, will be able to be examined immediately and accurately. The company's technology enables scanning electron microscopes (SEM) to image and analyze wet samples such as cells, tissue biopsies, foods and ink, in their native environment. QuantomiX was founded in March 2001 by Micha Brunstein, Zachy Berger and Ory S. Zik and is headquartered in Rehovot, Israel.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Adicet Bio Israel Ltd. develops therapeutic molecules for cancer, viral, and autoimmune diseases. The firm’s technologies include AIT develops a therapeutic antibodies T-Cell Receptor Like. Its TCRL antibodies have diagnostic applications in pathology, vaccine design, validation, and monitoring. The company was founded by Mira Peled-Kamar and Yoram Reiter in 2006 and is headquartered in Haifa, Israel.

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.